PT Ikapharmindo Putramas Tbk Share Price

Equities

IKPM

ID1000199409

Pharmaceuticals

End-of-day quote INDONESIA S.E. 23:00:00 13/05/2024 BST 5-day change 1st Jan Change
242 IDR -3.20% Intraday chart for PT Ikapharmindo Putramas Tbk -3.20% +19.80%

Financials

Sales 2022 399B 24.72M 1.98B Sales 2023 441B 27.35M 2.19B Capitalization 340B 21.1M 1.69B
Net income 2022 16.58B 1.03M 82.18M Net income 2023 15.34B 951K 76.03M EV / Sales 2022 * -
Net Debt 2022 133B 8.27M 661M Net Debt 2023 105B 6.52M 521M EV / Sales 2023 1.01 x
P/E ratio 2022 *
-
P/E ratio 2023
-
Employees 823
Yield 2022 *
-
Yield 2023
-
Free-Float 20%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.20%
1 week-3.20%
Current month+3.42%
1 month-21.43%
3 months-3.97%
6 months+39.88%
Current year+19.80%
More quotes
1 week
236.00
Extreme 236
256.00
1 month
210.00
Extreme 210
332.00
Current year
202.00
Extreme 202
332.00
1 year
164.00
Extreme 164
332.00
3 years
164.00
Extreme 164
332.00
5 years
164.00
Extreme 164
332.00
10 years
164.00
Extreme 164
332.00
More quotes
Date Price Change Volume
14/05/24 242 -3.20% 7,370,600
13/05/24 250 +1.63% 7,974,000
08/05/24 246 -1.60% 1,923,100
07/05/24 250 -0.79% 2,246,800

End-of-day quote INDONESIA S.E., May 13, 2024

More quotes
PT Ikapharmindo Putramas Tbk. is an Indonesia-based company, which is engaged in the marketing of pharmaceutical products and consumer health products located in Jakarta, Indonesia. The Company operates through two segments: Non Pharma, Pharma, and Contract manufacturing. The Company is focused on a diverse portfolio for the Indonesian market, with brands in the pharmaceutical product categories of prescription medicines, over the counter (OTC), nutraceuticals, professional hair care products and baby products. Its prescription pharmaceuticals include neurology, dermatology, gastroenterology, and cardiology. Its consumer division products consist of professional and retail haircare products, and also Baby HUKI, which consists of baby bottles and pacifiers, and other baby feeding equipment.
More about the company